loadpatents
name:-0.027431964874268
name:-0.005112886428833
name:-0.0009608268737793
Bova; David J. Patent Filings

Bova; David J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bova; David J..The latest application filed is for "methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics".

Company Profile
0.4.25
  • Bova; David J. - Chapel Hill NC
  • Bova; David J - Boca Raton FL
  • Bova; David J. - Boca Raton FL
  • Bova; David J. - Hollywood FL
  • Bova; David J. - Highland Beach FL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods For Treating Hyperlipidemia With Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics
App 20140113939 - Cefali; Eugenio ;   et al.
2014-04-24
Methods For Treating Hyperlipidemia With Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics
App 20130005779 - Cefali; Eugenio A. ;   et al.
2013-01-03
Nicotinic Acid Compositions For Treating Hyperlipidemia And Related Methods Therefor
App 20120245207 - Bova; David J.
2012-09-27
Methods For Treating Hyperlipidemia With Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics
App 20120202855 - Cefali; Eugenio A. ;   et al.
2012-08-09
Combinations Of Hmg-coa Reductase Inhibitors And Nicotinic Acid Compounds And Methods For Treating Hyperlipidemia Once A Day At Night
App 20120164221 - Bova; David J. ;   et al.
2012-06-28
Nicotinic Acid Compositions For Treating Hyperlipidemia And Related Methods Therefor
App 20120157503 - Bova; David J.
2012-06-21
Intermediate Release Nicotinic Acid Compositions For Treating Hyperlipidemia Which Exhibit An In Vivo Stair-stepped Absorption Curve
App 20120157685 - Cefali; Eugenio A. ;   et al.
2012-06-21
Methods And Sustained Release Nicotinic Acid Compositions For Treating Hyperlipidemia
App 20110301207 - Bova; David J.
2011-12-08
Nicotinic Acid Compositions For Treating Hyperlipidemia And Related Methods Therefor
App 20110245298 - Bova; David J.
2011-10-06
Nicotinic Acid Compositions For Treating Hyperlipidemia And Related Methods Therefor
App 20110245299 - Bova; David J.
2011-10-06
Nicotinic Acid Compositions For Treating Hyperlipidemia And Related Methods Therefor
App 20110245300 - Bova; David J.
2011-10-06
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
Grant 7,998,506 - Bova August 16, 2
2011-08-16
Nicotinic Acid Compositions For Treating Hyperlipidemia And Related Methods Therefor
App 20110003783 - Bova; David J.
2011-01-06
Intermediate Release Nicotinic Acid Compositions For Treating Hyperlipidemia Which Exhibit An In Vivo Stair-stepped Absorption Curve
App 20100240899 - Cefali; Eugenio A. ;   et al.
2010-09-23
(monitoring Only) Combinations Of Hmg-coa Reductase Inhibitors And Nicotinic Acid Compounds And Methods For Treating Hypelipidemia Once A Day At Night
App 20090226518 - Bova; David J. ;   et al.
2009-09-10
Nicotinic Acid Compositions For Treating Hyperlipidemia And Related Methods Therefor
App 20090203748 - Bova; David J.
2009-08-13
Nicotinic Acid Compositions For Treating Hyperlipidemia And Related Methods Therefor
App 20090186925 - Bova; David J.
2009-07-23
Nicotinic Acid Compositions For Treating Hyperlipidemia And Related Methods Therefor
App 20090036500 - Bova; David J.
2009-02-05
Nicotinic Acid Compositions For Treating Hyperlipidemia And Related Methods Therefor
App 20080300284 - Bova; David J.
2008-12-04
Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
App 20080045573 - Bova; David J.
2008-02-21
Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor
App 20070225342 - Bova; David J.
2007-09-27
Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor
App 20070225341 - Bova; David J.
2007-09-27
Hydrophobic component free sustained release nicotinic acid compositions for treating hyperlipidemia and related methods therefor
Grant 7,011,848 - Bova March 14, 2
2006-03-14
Combinations of HMG-COA reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
App 20050255158 - Bova, David J. ;   et al.
2005-11-17
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
App 20050118257 - Bova, David J.
2005-06-02
Intermediate release nicotinic acid compositions for treating hyperlipidemia
Grant 6,818,229 - Cefali , et al. November 16, 2
2004-11-16
Combinations of HMG-CoA reductase inhibitors and nicotinic acid compounds and methods for treating hypelipidemia once a day at night
App 20040053975 - Bova, David J. ;   et al.
2004-03-18
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
Grant 6,676,967 - Cefali , et al. January 13, 2
2004-01-13
Combinations Of Hmg-coa Reductase Inhibitors And Nicotinic Acid And Methods For Treating Hyperlipidemia Once A Day At Night
App 20010006644 - BOVA, DAVID J. ;   et al.
2001-07-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed